The impact of neoadjuvant hormone therapy on the permanent 125I-seed brachytherapy for low- or intermediate-risk prostate cancer. Does salvage radiation therapy (SRT) change the biology of recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback